Total submissions: 13
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mayo Clinic Laboratories, |
RCV000724394 | SCV007135341 | uncertain significance | not provided | 2025-09-09 | criteria provided, single submitter | clinical testing | |
| Department of Pathology and Laboratory Medicine, |
RCV005394232 | SCV006057595 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2023-10-19 | criteria provided, single submitter | research | |
| CHEO Genetics Diagnostic Laboratory, |
RCV003486596 | SCV004240107 | likely benign | Cardiomyopathy | 2023-02-24 | criteria provided, single submitter | clinical testing | |
| Revvity Omics, |
RCV000724394 | SCV003818515 | uncertain significance | not provided | 2024-07-05 | criteria provided, single submitter | clinical testing | |
| Genetics and Genomics Program, |
RCV001293173 | SCV001434170 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
| Center for Advanced Laboratory Medicine, |
RCV000852812 | SCV000995541 | likely benign | Ventricular tachycardia | 2019-04-01 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV000621675 | SCV000735262 | likely benign | Cardiovascular phenotype | 2020-03-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Labcorp Genetics |
RCV000534367 | SCV000643652 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-10-27 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV000724394 | SCV000237534 | likely benign | not provided | 2021-01-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24503780) |
| Eurofins Ntd Llc |
RCV000724394 | SCV000228537 | uncertain significance | not provided | 2014-11-23 | criteria provided, single submitter | clinical testing | |
| Laboratory for Molecular Medicine, |
RCV000040598 | SCV000064289 | uncertain significance | not specified | 2012-04-11 | criteria provided, single submitter | clinical testing | The Asn22275Asp variant (TTN) has not been previously reported nor previously id entified by our laboratory. Computational analyses (biochemical amino acid prope rties, conservation, AlignGVGD, and SIFT) do not provide strong support for or a gainst an impact to the protein. Additional information is needed to assess the clinical significance of this variant. |
| Clinical Genetics, |
RCV000724394 | SCV001919772 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
| Genome Diagnostics Laboratory, |
RCV000724394 | SCV001809175 | uncertain significance | not provided | no assertion criteria provided | clinical testing |